Preparation of ultrafine fenofibrate powder by solidification process from emulsion

International Journal of Pharmaceutics

Volumn 368, Issue 1-2, 2009, Pages 160-164

  Huang, Qiao Ping ^a   Wang, Jie Xin ^a   Zhang, Zhi Bing ^a   Shen, Zhi Gang ^a,b   Chen, Jian Feng ^a   Yun, Jimmy ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b NanoMaterials Technology Pte Ltd   (Singapore)

Author keywords

Emulsion; Fenofibrate; Poorly water soluble drug; Solidification; Ultrafine powder

Indexed keywords

EMULSIFYING AGENT; FENOFIBRATE; WATER;

ARTICLE; CHEMICAL REACTION; CRYSTAL; DISSOLUTION; DRUG MANUFACTURE; DRUG SOLUBILITY; EMULSION; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SOLIDIFICATION; ULTRAFINE POWDER;

ANTILIPEMIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; EMULSIFYING AGENTS; EMULSIONS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDERS; PROCETOFEN; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; WATER; X-RAY DIFFRACTION;

EID: 58949095762     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.10.015     Document Type: Article

References (32)

1. Biradar S.V., Patil A.R., Sudarsan G.V., and Pokharkar V.B. A comparative study of approaches used to improve solubility of roxithromycin. Powder Technol. 169 (2006) 22-32
2. Blasi P., Giovagnoli S., Schoubben A., Ricci M., and Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv. Drug Deliv. Rev. 59 (2007) 454-477
3. Chen H.B., Chang X.L., Du D.R., Li J., Xu H.B., and Yang X.L. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm. 315 (2006) 52-58
4. Curtet, B., Teillaud, E., Reginault, P., 1990. Novel dosage form of fenofibrate. US Patent 4,895,726, January 23.
5. Djordjevic L., Primorac M., Stupar M., and Krajisnik D. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int. J. Pharm. 271 (2004) 11-19
6. Drooge D.J.V., Hinrichs W.L.J., and Frijlink H.W. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J. Control. Release 97 (2004) 441-452
7. FeczkÓ T., TÓth J., and Gyenis J. Comparison of the preparation of PLGA-BSA nano- and microparticles by PVA, poloxamer and PVP. Colloids Surf. A: Physicochem. Eng. Aspects 319 (2008) 188-195
8. Friedrich H., Fussnegger B., Kolter K., and Bodmeier R. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur. J. Pharm. Biopharm. 62 (2006) 171-177
9. Füredi-Milhofer H., Garti N., and Kamyshny A. Crystallization from microemulsions-a novel method for the preparation of new crystal forms of aspartame. J. Cryst. Growth 198/199 (1999) 1365-1370
10. Grenler, P., Vergnault, G., Nhamias, A., 2005. Nanoparticulate formulations of fenofibrate. US Patent 2005/0095297, May 5.
11. Henry R.F., Zhang G.Z., Gao Y., and Buckner I.S. Fenofibrate. Acta Cryst. E59 (2003) o699-o700
12. Hu F.Q., Hong Y., and Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int. J. Pharm. 273 (2004) 29-35
13. Kan P., Chen Z.B., Kung R.Y., Lee C.J., and Chu I.M. Study on the formulation of O/W emulsion as carriers for lipophilic drug. Colloids Surf. B: Biointerf. 15 (1999) 117-125
14. Keck C.M., and Müller R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur. J. Pharm. Biopharm. 62 (2006) 3-16
15. Kharb V., Bhatia M., Dureja H., and Kaushik D. Nanoparticle technology for the delivery of poorly water-soluble drugs. Pharm. Technol. 2 (2006) 82-92
16. Lawrence M.J., and Rees G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45 (2000) 49-121
17. Mehnert W., and Mäder K. Solid lipid nanoparticles production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
18. Mosharraf M., and NyatrÖm C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int. J. Pharm. 122 (1995) 35-47
19. Müller R.H., Jacobs C., and Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47 (2001) 3-19
20. Müller R.H., and Peters K. Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique. Int. J. Pharm. 160 (1998) 229-237
21. Pace, G.W., Mishra, A.K., Snow, R.A., Parikh, I., Guivarc'h, P.W., 2004. Spray drying process and compositions of fenofibrate. US Patent 6,696,084, February 24.
22. Rasenack N., Steckel H., and Müller B.W. Preparation of microcrystals by in situ micronization. Powder Technol. 143-144 (2004) 291-296
23. Rath N.P., Haq W., and Balendiran G.K. Fenofibric acid. Acta Cryst. C61 (2005) o81-o84
24. Rhee Y.S., Choi J.G., Park E.S., and Chi S.C. Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 228 (2001) 161-170
25. Rogers T.L., Overhoft K.A., Shah P., Santiago P., Yacaman M.J., Johnston K.P., and Williams III R.O. Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process. Eur. J. Pharm. Biopharm. 55 (2003) 161-172
26. Stamm, A., Seth, P., 2000. Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it. US Patent 6,074,670, June 13.
27. Tamilvanan S. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Prog. Lipid Res. 43 (2004) 489-533
28. Tamilvanan S., and Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur. J. Pharm. Biopharm. 58 (2004) 357-368
29. Terayama H., Inada K., Nakayama H., Yasueda S., and Esumi K. Preparation of stable aqueous suspension of a hydrophobic drug with polymers. Colloids Surf. B: Biointerf. 39 (2004) 159-164
30. Urbán-Morlán Z., Castro-Ríos R., Chávez-Montes A., Melgoza-Contreras L.M., PiñÓn-Segundo E., Ganem-Quintanar A., and Quintanar-Guerrero D. Determination of poloxamer 188 and poloxamer 407 using high-performance thin-layer chromatography in pharmaceutical formulations. J. Pharm. Biomed. Anal. 46 (2008) 799-803
31. Wang Z., Chen J.F., Le Y., and Shen Z.G. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind. Eng. Chem. Res. 46 (2007) 4839-4845
32. Xu Y.L. Functions of Surfactants (2000), Chemical Industry Press, Beijing pp. 117-120